Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001173EBVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS42001179EBVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS10047480HBVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS10047481HBVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS30002926HIVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS30047373HIVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS30047374HIVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS44034039HTLV-1ENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS44034038HTLV-1ENSG00000167658.16protein_codingEEF2NoNo1938P13639
TVIS45000034MCVENSG00000167658.16protein_codingEEF2NoNo1938P13639
TCGA Plot Options
Drug Information
GeneEEF2
DrugBank IDDB11823
Drug NameEsketamine
Target IDBE0004281
UniProt IDP13639
Regulation Typeinhibitor
PubMed IDs29736744; 29516301
CitationsMolero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sanchez E, Gutierrez-Rojas L, Meana JJ: Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review. CNS Drugs. 2018 May;32(5):411-420. doi: 10.1007/s40263-018-0519-3.@@Zanos P, Thompson SM, Duman RS, Zarate CA Jr, Gould TD: Convergent Mechanisms Underlying Rapid Antidepressant Action. CNS Drugs. 2018 Mar;32(3):197-227. doi: 10.1007/s40263-018-0492-x.
GroupsApproved; Investigational
Direct ClassificationChlorobenzenes
SMILESCN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Pathways
PharmGKB
ChEMBLCHEMBL395091